FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES SALE OF ITS SHARES IN GENETX TO ULTRAGENYX ...Middle East

Ultragenyx exercises exclusive option to acquire GeneTx in order to further advance development of GTX-102 for the treatment of Angelman syndrome AUSTIN, Texas, July 18, 2022 /PRNewswire/ -- The Foundation for Angelman Syndrome Therapeutics (FAST) today announced that Ultragenyx...

Hence then, the article about foundation for angelman syndrome therapeutics fast announces sale of its shares in genetx to ultragenyx was published today ( Monday 18/07/2022 - 11:20 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES SALE OF ITS SHARES IN GENETX TO ULTRAGENYX )

Also on site :

• US cable outlines new ‘construct’ to control Strait of Hormuz – media
• Why are Western feminists silent on the war on Iranian women?
• ’80s Thrash Metal Frontman, Who Survived Rare Cancer, Announces New Project